Submitted: 12 Apr 2015
Accepted: 13 May 2015
ePublished: 07 Jun 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Endocrinol. 2015;1(1): e07.
  Abstract View: 470
  PDF Download: 492

Hypothesis

Hypomagnesemia and cisplatin nephrotoxicity

Hamid Nasri *

1 Nickan Research Institute, Isfahan, Iran.
*Corresponding author: Professor Hamid Nasri, hamidnasri@med.mui.ac.ir
Keywords: Magnesium, Cisplatin, Nephropathy

Please cite this paper as: Nasri H. Hypomagnesemia and cisplatin nephrotoxicity. J Renal Endocrinol. 2015;1:e07.

Implication for health policy/practice/research/medical education

Hypomagnesemia develops after cisplatin therapy and magnesium therapy is suggested to patients to prevent the hypomagnesemia after cisplatin therapy. Supplementation of magnesium may promote kidney toxicity of cisplatin, and therefore further studies are required to determine the exact role of magnesium in cisplatin metabolism.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 470

Your browser does not support the canvas element.


PDF Download: 492

Your browser does not support the canvas element.